[1] |
OVERHAGE J, CAMPISANO A, BAINS M, et al. Human host defense peptide LL-37 prevents bacterial biofilm formation[J]. Infect Immun, 2008, 76(9):4176-4182.
|
[2] |
BATONI G, MAISETTA G, ESIN S. Therapeutic potential of antimicrobial peptides in polymicrobial biofilm-associated infections[J]. Int J Mol Sci, 2021, 22(2):482.
|
[3] |
张 阳, 程 鹏, 李晓芬, 等. 抗生物膜肽研究进展[J]. 生物技术通报, 2021, 37(2):216-223.ZHANG Y, CHENG P, LI X F, et al. Research progress on anti-biofilm peptides[J]. Biotechnology Bulletin, 2021, 37(2):216-223. (in Chinese)
|
[4] |
STARR C G, GHIMIRE J, GUHA S, et al. Synthetic molecular evolution of host cell-compatible, antimicrobial peptides effective against drug-resistant, biofilm-forming bacteria[J]. Proc Natl Acad Sci U S A, 2020, 117(15):8437-8448.
|
[5] |
GALLO R L, KIM K J, BERNFIELD M, et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse[J]. J Biol Chem, 1997, 272(20):13088-13093.
|
[6] |
ZHOU Q L, PAN L L, XUE R C, et al. The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure[J]. Theranostics, 2020, 10(14):6167-6181.
|
[7] |
YU K, PARK K, KANG S W, et al. Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy[J]. J Pept Res, 2002, 60(1):1-9.
|
[8] |
CHEN H W, WUBBOLTS R W, HAAGSMAN H P, et al. Inhibition and eradication of Pseudomonas aeruginosa biofilms by host defence peptides[J]. Sci Rep, 2018, 8(1):10446.
|
[9] |
ZHANG Y, HE X, CHENG P, et al. Effects of a novel anti-biofilm peptide CRAMP combined with antibiotics on the formation of Pseudomonas aeruginosa biofilms[J]. Microb Pathog, 2021, 152:104660.
|
[10] |
张 阳, 程 鹏, 熊 静, 等. 基于RNA-Seq技术分析鼠源宿主防御肽对铜绿假单胞菌成熟生物被膜的清除作用[J]. 微生物学报, 2021, 61(9):2843-2853.ZHANG Y, CHENG P, XIONG J, et al. Eradication effect of Pseudomonas aeruginosa biofilms by mouse host defense peptide based on RNA-Seq technology[J]. Acta Microbiologica Sinica, 2021, 61(9):2843-2853. (in Chinese)
|
[11] |
MOHANRAM H, BHATTACHARJYA S. Resurrecting inactive antimicrobial peptides from the lipopolysaccharide trap[J]. Antimicrob Agents Chemother, 2014, 58(4):1987-1996.
|
[12] |
KUMAR P, NAGARAJAN A, UCHIL P D. Analysis of cell viability by the lactate dehydrogenase assay[J]. Cold Spring Harb Protoc, 2018, 2018(6), doi:10. 1101/pdb. prot095497.
|
[13] |
THERY T, O'CALLAGHAN Y, O'BRIEN N, et al. Optimisation of the antifungal potency of the amidated peptide H-Orn-Orn-Trp-Trp-NH2 against food contaminants[J]. Int J Food Microbiol, 2018, 265:40-48.
|
[14] |
SUN C B, LI Y Y, CAO S S, et al. Antibacterial activity and mechanism of action of bovine lactoferricin derivatives with symmetrical amino acid sequences[J]. Int J Mol Sci, 2018, 19(10):2951.
|
[15] |
KIM H, JANG J H, KIM S C, et al. De novo generation of short antimicrobial peptides with enhanced stability and cell specificity[J]. J Antimicrob Chemother, 2014, 69(1):121-132.
|
[16] |
WU G Q, DING J X, LI H, et al. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 21332[J]. Curr Microbiol, 2008, 57(6):552-557.
|
[17] |
陈园园, 彭党聪. 生物膜中EPS与微生物的分布及测定[J]. 中国给水排水, 2017, 33(15):25-30, 35.CHEN Y Y, PENG D C. Distribution and determination of EPS and microorganisms in biofilm[J]. China Water & Wastewater, 2017, 33(15):25-30, 35. (in Chinese)
|
[18] |
王安田, 黄 靖, 宋炳晓, 等. 猪β防御素-2对猪链球菌感染小鼠的治疗效果评价[J]. 畜牧兽医学报, 2020, 51(12):3160-3170.WANG A T, HUANG J, SONG B X, et al. Evaluation of therapeutic effect of porcine β-defensin-2 on Streptococcus suis infection[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(12):3160-3170. (in Chinese)
|
[19] |
杨 磊, 杭柏林, 徐彦召, 等. 牛源抗菌肽BSN-37的生物活性[J]. 中国兽医学报, 2018, 38(11):2088-2093.YANG L, HANG B L, XU Y Z. Biological activity of a novel bovine-born antimicrobial peptide BSN-37[J]. Chinese Journal of Veterinary Science, 2018, 38(11):2088-2093. (in Chinese)
|
[20] |
SHIN S Y, KANG S W, LEE D G, et al. CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity[J]. Biochem Biophys Res Commun, 2000, 275(3):904-909.
|
[21] |
ABBASSI F, LEQUIN O, PIESSE C, et al. Temporin-SHf, a new type of phe-rich and hydrophobic ultrashort antimicrobial peptide[J]. J Biol Chem, 2010, 285(22):16880-16892.
|
[22] |
SUN T Y, ZHAN B, GAO Y Y. A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria[J]. Gene, 2015, 571(2):172-177.
|
[23] |
COSTA G A, ROSSATTO F C P, MEDEIROS A W, et al. Evaluation antibacterial and antibiofilm activity of the antimicrobial peptide P34 against Staphylococcus aureus and Enterococcus faecalis[J]. An Acad Bras Cienc, 2018, 90(1):73-84.
|
[24] |
李 杨. Cathelicidin相关抗菌肽(CRAMP)在炎性肠病及哮喘小鼠模型中的免疫调控作用与机制[D]. 北京:北京协和医学院, 2016.LI Y. The inmunomodulation effects and mechanisms of cathelicidin-related antimicrobial peptide (CRAMP) in mouse models of intestinal colitis and asthma[D]. Beijing:Peking Union Medical College, 2016. (in Chinese)
|
[25] |
WINDERICKX S, DE BRUCKER K, BIRD M J, et al. Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33[J]. Peptides, 2018, 109:33-38.
|
[26] |
NAGARAM P, PASUPULETI M, AROCKIARAJ J. CxxC zinc finger protein derived peptide, MF18 functions against biofilm formation[J]. Protein J, 2020, 39(4):337-349.
|
[27] |
魏晓晓, 杭柏林, 马 翠, 等. 抗菌肽JH-3的抑菌活性及其稳定性分析[J]. 畜牧兽医学报, 2016, 47(2):361-366.WEI X X, HANG B L, MA C, et al. Analysis of antimicrobial activity and stability of antibacterial peptide JH-3[J]. Acta Veterinaria et Zootechnica Sinica, 2016, 47(2):361-366. (in Chinese)
|
[28] |
STARR C G, WIMLEY W C. Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes[J]. Biochim Biophys Acta Biomembr, 2017, 1859(12):2319-2326.
|
[29] |
戈家傲, 刘 畅, 龚建刚, 等. 抗菌环肽的研究进展[J]. 中国生物工程杂志, 2018, 38(11):76-83.GE J A, LIU C, GONG J G. Research progress of antibacterial cyclopeptides[J]. China Biotechnology, 2018, 38(11):76-83. (in Chinese)
|
[30] |
VINGOPOULOU E I, DELIS G A, BATZIAS G C, et al. Prevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in Greece[J]. Vet Microbiol, 2018, 213:102-107.
|
[31] |
YAN S M, WU G. Can biofilm be reversed through quorum sensing in Pseudomonas aeruginosa?[J]. Front Microbiol, 2019, 10:1582.
|
[32] |
李 玲. 鸡铜绿假单胞菌的分离鉴定及生物学特性研究[D]. 保定:河北农业大学, 2013.LI L. Isolation and identification and biological characteristics of pseudomonas aeruginosa isolted from chicken[D]. Baoding:Hebei Agricultural University, 2013. (in Chinese)
|
[33] |
AZAM M W, KHAN A U. Updates on the pathogenicity status of Pseudomonas aeruginosa[J]. Drug Discov Today, 2019, 24(1):350-359.
|
[34] |
RUMBAUGH K P, SAUER K. Biofilm dispersion[J]. Nat Rev Microbiol, 2020, 18(10):571-586.
|
[35] |
ZHAO K, TSENG B S, BECKERMAN B, et al. Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms[J]. Nature, 2013, 497(7449):388-391.
|